King Pharma Weighs Alternative Financing

King Pharmaceuticals is seeking financing alternatives to fund its $1.6 billion takeover of Alpharma, according to a filing with the Securities and Exchange Commission Wednesday.

  • 26 Nov 2008

King Pharmaceuticals is seeking financing alternatives to fund its $1.6 billion takeover of Alpharma, according to a filing with the Securities and Exchange Commission Wednesday. The announcement comes less than a week after banks launched a new facility intended to back the acquisition.

The filing says the alternate deal ...

Please take a trial or subscribe to access this content.

Contact Mark Goodes to discuss your access: mark.goodes@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Share % by Volume
1 Societe Generale 15.35
2 Rabobank 14.41
3 Morgan Stanley 11.73
4 Barclays 8.99
5 Credit Agricole 7.57

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 27 Feb 2017
1 Wells Fargo Securities 11,897.40 33 11.83%
2 Bank of America Merrill Lynch 9,837.56 29 9.78%
3 Citi 9,714.54 32 9.66%
4 JPMorgan 7,997.38 24 7.95%
5 Credit Suisse 6,335.67 14 6.30%